Kirske David Insider Trades

Insider Trading History

Track insider trading activity for Kirske David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Chief Financial Officer
Holding Value $707k 176,293 shares
Last Trade
May 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.8k 16,961 shares
$4.29
$4.01
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Chief Financial Officer
Holding Value $6.23M 1,552,769 shares
Last Trade
Oct 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.81M 1,552,769 shares
$3.74
$4.01
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Chief Financial Officer
Holding Value $1.41M 352,800 shares
Last Trade
Aug 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.11M 352,800 shares
$3.14
$4.01
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Chief Financial Officer
Holding Value $4.3M 1,073,249 shares
Last Trade
Aug 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.77M 1,073,249 shares
$2.58
$4.01
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.46M 270,216 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.36M 150,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.86M 315,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$227k 25,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.55M 280,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$758k 83,396 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$160k 17,547 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.09M 340,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.82M 200,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $1.82M 200,000 shares
Last Trade
Mar 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$910k 200,000 shares
$4.55
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $156k 17,127 shares
Last Trade
Jan 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$162k 27,021 shares
$6.01
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $2.46M 270,216 shares
Last Trade
Jan 03, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 27,021 shares
$5.86
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $402k 44,148 shares
Last Trade
Jan 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 27,021 shares
$5.86
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $2.72M 299,084 shares
Last Trade
Dec 30, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$83.2k 13,847 shares
$6.01
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $265k 29,127 shares
Last Trade
Dec 30, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$83.2k 13,847 shares
$6.01
$9.10
CTI BioPharma
CTI BioPharma CTIC
Evp, Chief Financial Officer
Holding Value $156k 17,127 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29k 214 shares
$6.01
$9.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up